Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma

Background: Hepatocellular carcinoma (HCC) is one of the most malignant tumors. The in vitro experiments on the application of Anhydroicaritin (AHI), the active ingredient of Bushen Huayu Decoction, in HCC treatment remain limited, particularly regarding its molecular mechanism. Methods: The TCMSP p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Houhong, Chen, Wenli, Cui, Yayun, Gong, Huihui, Tang, Amao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457047/
https://www.ncbi.nlm.nih.gov/pubmed/37556351
http://dx.doi.org/10.18632/aging.204948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457047/
https://www.ncbi.nlm.nih.gov/pubmed/37556351
http://dx.doi.org/10.18632/aging.204948

Ejemplares similares